First patient dosed in phase I trial of BAX-826 for the treatment of hemophilia A March 7, 2016 No Comments
FDA grants orphan drug designation to BMN-270 gene therapy for hemophilia A March 2, 2016 No Comments
Evgen cleared to begin phase II trial of SFX-01 for aneurysmal subarachnoid hemorrhage March 2, 2016 No Comments
Baxalta seeks FDA approvals for Adynovate for use in pediatric patients and surgical settings Feb. 29, 2016 No Comments
EMA grants orphan drug designation to TNT-009 for autoimmune hemolytic anemia Feb. 26, 2016 No Comments
RSS